{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:32:34Z","timestamp":1790947954563,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T00:00:00Z","timestamp":1551225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100014408","name":"National Institute of Geriatrics, Rheumatology and Rehabilitation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014408","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s10067-019-04438-z","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T15:12:16Z","timestamp":1551280336000},"page":"1301-1307","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Usefulness of rheumatoid factor as an immunological and prognostic marker in PSS patients"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2211-0302","authenticated-orcid":false,"given":"Maria","family":"Ma\u015bli\u0144ska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Ma\u0144czak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brygida","family":"Kwiatkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,27]]},"reference":[{"issue":"6","key":"4438_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1155\/2013\/726598","volume":"35","author":"F Ingegnoli","year":"2013","unstructured":"Ingegnoli F, Castelli R, Gualtierotti R (2013) Rheumatoid factor: clinicla applications. Dis Markers 35(6):727\u2013734","journal-title":"Dis Markers"},{"key":"4438_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1159\/000066861","volume":"6","author":"AM Haberman","year":"2003","unstructured":"Haberman AM, William J, Euler C, Shlomchik MJ (2003) Rheumatoid factors in health and disease: structure, function, induction and regulation. Curr Dir Autoimmun 6:169\u2013195","journal-title":"Curr Dir Autoimmun"},{"issue":"4","key":"4438_CR3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00296-009-0997-1","volume":"30","author":"E Orge","year":"2010","unstructured":"Orge E, Cefle A, Yazici A, G\u00fcrel-Polat N, Hulagu S (2010) The positivity of rheumatoid factor and anti-cyclic citrullinated peptide antibody in nonarthritic patients with chronic hepatitis C infection. Rheumatol Int 30(4):485\u2013488. \n                    https:\/\/doi.org\/10.1007\/s00296-009-0997-1","journal-title":"Rheumatol Int"},{"key":"4438_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/clim.2002.5210","volume":"104","author":"MM Newkirk","year":"2002","unstructured":"Newkirk MM (2002) Rheumatoid factors: host resistance or autoimmunity? Clin Immunol 104:1\u201313","journal-title":"Clin Immunol"},{"key":"4438_CR5","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1186\/ar4442","volume":"16","author":"D Cornec","year":"2014","unstructured":"Cornec D, Saraux A, Pers JO, Jousse-Joulin S, Marhadour T, Roguedas-Contios AM, Genestet S, Renaudineau Y, Devauchelle-Pensec V (2014) Diagnostic accuracy of blood B-cell subset profiling and autoimmunity markers in primary Sjogren\u2019s syndrome. Arthritis Res Ther 16:R15","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"4438_CR6","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.bbrc.2009.09.012","volume":"389","author":"T Mizuochi","year":"2009","unstructured":"Mizuochi T, Ito M, Takai K, Yamaguchi K (2009) Differential susceptibility of peripheral blood CD5+ and CD5- B cells to apoptosis in chronic hepatitis C patients. Biochem Biophys Res Commun 389(3):512\u2013515. \n                    https:\/\/doi.org\/10.1016\/j.bbrc.2009.09.012","journal-title":"Biochem Biophys Res Commun"},{"key":"4438_CR7","doi-asserted-by":"publisher","first-page":"e5244","DOI":"10.1136\/bmj.e5244","volume":"345","author":"SF Nielsen","year":"2012","unstructured":"Nielsen SF, Bojeson SE, Schnohr P, Nordestaarg BG (2012) Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study. BMJ 345:e5244","journal-title":"BMJ"},{"key":"4438_CR8","doi-asserted-by":"publisher","first-page":"e5841","DOI":"10.1136\/bmj.e5841","volume":"345","author":"JF Simard","year":"2012","unstructured":"Simard JF (2012) Rheumatoid factor positivity in the general population. Is unlikely to be discovered incidentally. BMJ 345:e5841","journal-title":"BMJ"},{"key":"4438_CR9","first-page":"1129","volume":"44","author":"MM Newkirk","year":"1998","unstructured":"Newkirk MM, Lepage K, Niwa T, Rubin L (1998) Advanced glycation endproducts (AGE) on IgG, a target for circulating antibodies in North American Indians with Rheumatoid Arthritis (RA). Cell Molec Biol 44:1129\u20131138","journal-title":"Cell Molec Biol"},{"key":"4438_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jaut.2010.06.012","volume":"35","author":"CP Mavragani","year":"2010","unstructured":"Mavragani CP, Crow MK (2010) Activation of the type I interferon pathway in primary Sj\u00f6gren\u2019s syndrome. J Autoimmun 35:225\u2013231","journal-title":"J Autoimmun"},{"key":"4438_CR11","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/ar3348","volume":"13","author":"P Youinou","year":"2011","unstructured":"Youinou P, Pers JO (2011) Disturbance of cytokine networks in Sj\u00f6gren\u2019s syndrome. Arthritis Res Ther 13:227","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"4438_CR12","first-page":"1352","volume":"31","author":"C Diaz-Lopez","year":"2004","unstructured":"Diaz-Lopez C, Geli C, Corominasetal H (2004) Are there clinical or serological differences between male and female patients with primary Sj\u00f6gren\u2019s syndrome? J Rheumatol 31(7):1352\u20131355","journal-title":"J Rheumatol"},{"key":"4438_CR13","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/acr.21591","volume":"64","author":"SC Shiboski","year":"2012","unstructured":"Shiboski SC, Shiboski CH, Criswell L et al (2012) American College of Rheumatology classification criteria for Sj\u00f6gren\u2019s syndrome: a data-driven, expert consensus approach in the Sj\u00f6gren\u2019s International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) 64:475\u2013487","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"4438_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/00005792-200207000-00004","volume":"81","author":"M Ramos-Casals","year":"2002","unstructured":"Ramos-Casals M, Font J, Garcia-Carrasco M, , et al. Primary Sjogren syndrome: hematologic patterns of disease expression. (2002) Medicine (Baltimore) 81: 281\u2013292","journal-title":"Medicine (Baltimore)"},{"key":"4438_CR15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s002960050112","volume":"19","author":"T Witte","year":"2000","unstructured":"Witte T, Hartung K, Sachse C et al (2000) Rheumatoid factors in systemic lupus erythematosus: association with clinical and laboratory parameters. SLE study group. Rheumatol Int 19:107\u2013111","journal-title":"Rheumatol Int"},{"key":"4438_CR16","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/art.39518","volume":"68","author":"G Nocturne","year":"2016","unstructured":"Nocturne G, Virone A, Ng W-F, le Guern V, Hachulla E, Cornec D, Daien C, Vittecoq O, Bienvenu B, Marcelli C, Wendling D, Amoura Z, Dhote R, Lavigne C, Fior R, Gottenberg JE, Seror R, Mariette X (2016) Rheumatoid factor and disease activity are independent predictors of lymphoma in primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol 68:977\u2013985","journal-title":"Arthritis Rheumatol"},{"key":"4438_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12865-017-0234-8","volume":"18","author":"S Watanabe","year":"2017","unstructured":"Watanabe S, Gono T, Nishina K, Sugitani N, Watanabe E, Yabe H, Terai C (2017) Rheumatoid factor is correlated with disease activity and inflammatory markers in antineutrophil cytoplasmic antibody- associated vasculitis. BMC Immunol 18:53","journal-title":"BMC Immunol"},{"issue":"3","key":"4438_CR18","first-page":"121","volume":"36 Suppl 112","author":"A Flores-Ch\u00e1vez","year":"2018","unstructured":"Flores-Ch\u00e1vez A, Kostov B, Solans R et al (2018) Severe, life-threatening phenotype of primary Sj\u00f6gren\u2019s syndrome: clinical characterisation and outcomes in 1580 patients (GEAS-SS Registry). Clin Exp Rheumatol 36 Suppl 112(3):121\u2013129","journal-title":"Clin Exp Rheumatol"},{"key":"4438_CR19","doi-asserted-by":"publisher","unstructured":"Birnbaum J, Lalji A, Saed A, Baer AN (2018) Biopsy-proven small-fiber neuropathy in primary Sj\u00f6gren\u2019s syndrome: neuropathic pain characteristics, autoantibody findings, and histopathological features. Arthritis Care Res (Hoboken). \n                    https:\/\/doi.org\/10.1002\/acr.23762","DOI":"10.1002\/acr.23762"},{"key":"4438_CR20","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1136\/annrheumdis-2012-202293","volume":"72","author":"JE Gottenberg","year":"2013","unstructured":"Gottenberg JE, Cinquetti G, Larroche C et al (2013) Efficacy of rituximab in systemic manifestations of primary Sjogren\u2019s syndrome: results in 78 patients of the Autoimmune and Rituximab registry. Ann Rheum Dis 72:1026\u20131031","journal-title":"Ann Rheum Dis"},{"key":"4438_CR21","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/rheumatology\/keu417","volume":"54","author":"PR Sada","year":"2015","unstructured":"Sada PR, Isenberg D, Ciurtin C (2015) Biologic treatment in Sj\u00f6gren\u2019s syndrome. Rheumatology (Oxford) 54:219\u2013230","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"4438_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.semarthrit.2012.11.007","volume":"43","author":"RJ Maneiro","year":"2013","unstructured":"Maneiro RJ, Salgado E, Carmona L, Gomez-Reino JJ (2013) Rheumatoid factor as predictor of response to abatacept, rituximab and tocilizumab in rheumatoid arthritis: systematic review and meta-analysis. Semin Arthritis Rheum 43(1):9\u201317","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"4438_CR23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1136\/annrheumdis-2011-201117","volume":"72","author":"JD Isaacs","year":"2013","unstructured":"Isaacs JD, Cohen SB, Emery P, Tak PP, Wang J, Lei G, Williams S, Lal P, Read SJ (2013) Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis. Ann Rheum Dis 72(3):329\u2013336","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4438_CR24","doi-asserted-by":"publisher","first-page":"R20","DOI":"10.1186\/ar4152","volume":"15","author":"JD Jones","year":"2013","unstructured":"Jones JD, Shyu I, Newkirk MM, Rigby WF (2013) A rheumatoid factor paradox: inhibition of rituximab effector function. Arthritis Res Ther 15(1):R20","journal-title":"Arthritis Res Ther"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-019-04438-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04438-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04438-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T19:24:21Z","timestamp":1582745061000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-019-04438-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,27]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["4438"],"URL":"https:\/\/doi.org\/10.1007\/s10067-019-04438-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,27]]},"assertion":[{"value":"4 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures were performed according to Helsinki Declaration. The approval of the Bioethics Committee of National Institute of Geriatrics, Rheumatology, and Rehabilitation was obtained.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}